D'Erasmo Michael P, Masaoka Takashi, Wilson Jennifer A, Hunte Errol M, Beutler John A, Le Grice Stuart F J, Murelli Ryan P
Department of Chemistry, Brooklyn College, The City University of New York, Brooklyn, New York, USA; PhD Program in Chemistry, The Graduate Center of The City University of New York, New York, NY, USA.
Basic Research Laboratory, National Cancer Institute, Frederick, MD, USA.
Medchemcomm. 2016 Sep 1;7(9):1789-1792. doi: 10.1039/C6MD00237D. Epub 2016 Jul 7.
α-Hydroxytropolones are established inhibitors of several therapeutically relevant binuclear metalloenzymes, and thus lead drug targets for various human diseases. We have leveraged a recently-disclosed three-component oxidopyrylium cycloaddition in the first solid-phase synthesis of α-hydroxytropolones. We also showed that, while minor impurities exist after cleavage and aqueous wash, the semi-crude products display activity in HIV RT-associated RNaseH enzymatic and cell-based assays consistent with pure molecules made in solution phase. These proof-of-principle studies demonstrate the feasibility of solid-phase α-hydroxytropolone synthesis and its potential to serve as a powerful platform for α-hydroxytropolone-based drug discovery and development.
α-羟基托酚酮是几种具有治疗意义的双核金属酶的既定抑制剂,因此是多种人类疾病的潜在药物靶点。我们利用最近披露的三组分氧化吡啶环加成反应首次实现了α-羟基托酚酮的固相合成。我们还表明,虽然在裂解和水洗后存在少量杂质,但半粗产物在HIV逆转录酶相关的核糖核酸酶H酶促和细胞实验中表现出与溶液相合成的纯分子一致的活性。这些原理验证研究证明了固相合成α-羟基托酚酮的可行性及其作为基于α-羟基托酚酮的药物发现和开发强大平台的潜力。